USA - NYSE:GMRE - US37954A3032 - REIT
The current stock price of GMRE is 32.175 USD. In the past month the price increased by 5.03%. In the past year, price decreased by -27.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 131.02 | 127.06B | ||
| VTR | VENTAS INC | 146.17 | 34.54B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.46 | 12.87B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 88.75 | 12.33B | ||
| ARE | ALEXANDRIA REAL ESTATE EQUIT | N/A | 9.57B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | 109.46 | 8.49B | ||
| CTRE | CARETRUST REIT INC | 26.63 | 8.15B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.30B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 26.19 | 4.52B | ||
| DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.24B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.01B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.33 | 3.64B |
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company is headquartered in Bethesda, Maryland and currently employs 26 full-time employees. The company went IPO on 2012-11-02. The firm acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The firm conducts its business through a wholly owned subsidiary of its operating partnership, Global Medical REIT L.P. The company owns 92.6% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.4% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. The firm's portfolio is located in various areas, including Texas, Florida, Ohio, Pennsylvania, Illinois, Arizona, and Michigan.
GLOBAL MEDICAL REIT INC
7373 Wisconsin Avenue, Suite 800
Bethesda MARYLAND 20814 US
CEO: Jeffrey M. Busch
Employees: 26
Phone: 12025246851
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company is headquartered in Bethesda, Maryland and currently employs 26 full-time employees. The company went IPO on 2012-11-02. The firm acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The firm conducts its business through a wholly owned subsidiary of its operating partnership, Global Medical REIT L.P. The company owns 92.6% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.4% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. The firm's portfolio is located in various areas, including Texas, Florida, Ohio, Pennsylvania, Illinois, Arizona, and Michigan.
The current stock price of GMRE is 32.175 USD. The price decreased by -0.54% in the last trading session.
GLOBAL MEDICAL REIT INC (GMRE) has a dividend yield of 7.69%. The yearly dividend amount is currently 4.96.
GMRE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
GMRE stock is listed on the New York Stock Exchange, Inc. exchange.
16 analysts have analysed GMRE and the average price target is 43.48 USD. This implies a price increase of 35.13% is expected in the next year compared to the current price of 32.175.
GLOBAL MEDICAL REIT INC (GMRE) operates in the Real Estate sector and the Diversified REITs industry.
ChartMill assigns a technical rating of 1 / 10 to GMRE. When comparing the yearly performance of all stocks, GMRE is a bad performer in the overall market: 81.96% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to GMRE. GMRE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months GMRE reported a non-GAAP Earnings per Share(EPS) of 0.17. The EPS increased by 950% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.15% | ||
| ROA | 0.34% | ||
| ROE | 0.89% | ||
| Debt/Equity | 1.39 |
16 analysts have analysed GMRE and the average price target is 43.48 USD. This implies a price increase of 35.13% is expected in the next year compared to the current price of 32.175.
For the next year, analysts expect an EPS growth of 480.13% and a revenue growth 6.91% for GMRE